These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19501211)

  • 21. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
    Klipping C; Duijkers I; Trummer D; Marr J
    Contraception; 2008 Jul; 78(1):16-25. PubMed ID: 18555813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel ethinyl estradiol-beta-cyclodextrin clathrate formulation does not influence the relative bioavailability of ethinyl estradiol or coadministered drospirenone.
    Blode H; Schürmann R; Benda N
    Contraception; 2008 Mar; 77(3):171-6. PubMed ID: 18279686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days.
    Foidart JM; Sulak PJ; Schellschmidt I; Zimmermann D;
    Contraception; 2006 Jan; 73(1):34-40. PubMed ID: 16371292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20microg and drospirenone 3mg.
    Cibula D; Karck U; Weidenhammer HG; Kunz J; Alincic S; Marr J
    Clin Drug Investig; 2006; 26(3):143-50. PubMed ID: 17163245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
    Koltun W; Maloney JM; Marr J; Kunz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):171-5. PubMed ID: 21288628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
    Borges LE; Andrade RP; Aldrighi JM; Guazelli C; Yazlle ME; Isaia CF; Petracco A; Peixoto FC; Camargos AF
    Contraception; 2006 Dec; 74(6):446-50. PubMed ID: 17157100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
    Portman DJ; Kaunitz AM; Howard B; Weiss H; Hsieh J; Ricciotti N
    Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
    Pearlstein TB; Bachmann GA; Zacur HA; Yonkers KA
    Contraception; 2005 Dec; 72(6):414-21. PubMed ID: 16307962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo.
    Poindexter A; Reape KZ; Hait H
    Contraception; 2008 Aug; 78(2):113-9. PubMed ID: 18672111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism].
    Lello S; Pacifico V; Primavera G; Guardianelli F; Sorge R; Paoletti AM; Melis GB; Raskovic D; Colonna L
    Minerva Ginecol; 2010 Dec; 62(6):509-13. PubMed ID: 21079572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China].
    Caiyan W; Wen D; Qinping L; Huan S; Ziyan H; Liangdan T; Zheng'ai X; Yufeng L; Shulan Z; Baihua D; Xiaoyan X; Mulan R; Xiaomao L; Youdi X; Zhisong M; Meiqing X; Hongyu W; Zirong H
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):355-9. PubMed ID: 25030732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
    Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Palombo-Kinne E; Kuhl H
    Contraception; 2011 Aug; 84(2):133-43. PubMed ID: 21757054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
    Oner G; Muderris II
    Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acceptability of a novel oral contraceptive containing drospirenone and its effect on well-being.
    Boschitsch E; Skarabis H; Wuttke W; Heithecker R
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():34-40. PubMed ID: 11246600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone.
    Blode H; Klipping C; Richard F; Trummer D; Rohde B; Diefenbach K
    Contraception; 2012 Feb; 85(2):177-84. PubMed ID: 22067789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women.
    Blode H; Foidart JM; Heithecker R
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):167-71. PubMed ID: 11763981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
    Douxfils J; Klipping C; Duijkers I; Kinet V; Mawet M; Maillard C; Jost M; Rosing J; Foidart JM
    Contraception; 2020 Dec; 102(6):396-402. PubMed ID: 32956694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomegestrol acetate/estradiol: in oral contraception.
    Yang LP; Plosker GL
    Drugs; 2012 Oct; 72(14):1917-28. PubMed ID: 22950535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles.
    Machado RB; de Melo NR; Maia H; Cruz AM
    Contraception; 2010 Feb; 81(2):102-6. PubMed ID: 20103445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.